Bevacizumab and Carboplatin for Patients With Ovarian Cancer

NCT00744718 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Bevacizumab
DRUG: Carboplatin

Sponsor

Vejle Hospital